Emerging Therapeutic Innovations for Vitiligo Treatment
Vitiligo is a chronic autoimmune disorder with a multifactorial etiology, typically manifesting as localized or generalized hypopigmentation or depigmentation of the skin and mucous membranes. The pathogenesis of vitiligo is complex and significantly impacts patients’ quality of life. Although tradi...
Saved in:
| Main Authors: | Weiran Li, Penghao Dong, Guiyuan Zhang, Junjie Hu, Sen Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Current Issues in Molecular Biology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1467-3045/47/3/191 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in the etiopathogenesis of vitiligo
by: Thomas Mathew, et al.
Published: (2024-12-01) -
Management of Generalized Vitiligo in Adolescent with Tofacitinib: Clinical Case
by: Eduard T. Ambarchyan, et al.
Published: (2024-11-01) -
Biomimetic polydopamine loaded with janus kinase inhibitor for synergistic vitiligo therapy via hydrogel microneedles
by: Chunying Li, et al.
Published: (2025-01-01) -
The efficacy of narrowband ultraviolet B phototherapy combination with tofacitinib in the treatment of vitiligo: a randomized controlled trial
by: Xiaoyan Guo, et al.
Published: (2025-12-01) -
Topical ruxolitinib for treatment-induced vitiligo in a patient with metastatic melanoma
by: Alpaslan Tasdogan, MD, PhD, et al.
Published: (2025-01-01)